Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Jun 13. doi: 10.1111/ajt.15493. [Epub ahead of print]

PMID:
31194283
2.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to non-sensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Jun 2. doi: 10.1111/ajt.15486. [Epub ahead of print]

PMID:
31155833
3.

Comparing Allografts to Autografts for Maintenance of Cervical Sagittal Parameters and Clinical Outcomes Following Anterior Cervical Discectomy and Fusion With Anterior Cervical Plating.

Heidt ST, Louie PK, Khan JM, Basques BA, Hirsch B, Varthi A, Paul JC, Goldberg EJ, An HS.

Neurospine. 2019 Feb 23. doi: 10.14245/ns.1836202.101. [Epub ahead of print]

4.

Reciprocal HLA-DR allogenicity between mother and child affects pregnancy outcome parameters.

Craenmehr MHC, van Egmond A, Haasnoot GW, Eikmans M, Roelen DL, Heidt S, Scherjon SA, Claas FHJ.

J Reprod Immunol. 2019 Apr 30;133:15-17. doi: 10.1016/j.jri.2019.04.002. [Epub ahead of print]

PMID:
31071643
5.

Obesity does not impact clinical outcome but affects cervical sagittal alignment and adjacent segment degeneration in short term follow-up after an anterior cervical decompression and fusion.

Basques BA, Khan JM, Louie PK, Mormol J, Heidt S, Varthi A, Paul JC, Goldberg EJ, An HS.

Spine J. 2019 Mar 23. pii: S1529-9430(19)30080-4. doi: 10.1016/j.spinee.2019.02.016. [Epub ahead of print]

PMID:
30914278
6.

Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.

Herrera-Gómez F, Del Aguila W, Tejero-Pedregosa A, Adler M, Padilla-Berdugo R, Maurtua-Briseño-Meiggs Á, Pascual J, Pascual M, San Segundo D, Heidt S, Álvarez FJ, Ochoa-Sangrador C, Lambert C.

Data Brief. 2018 Nov 27;21:2567-2575. doi: 10.1016/j.dib.2018.11.083. eCollection 2018 Dec.

7.

Towards the identification of the relative immunogenicity of individual HLA antibody epitopes.

Kramer C, Heidt S, Claas FHJ.

Hum Immunol. 2019 Apr;80(4):218-220. doi: 10.1016/j.humimm.2019.02.002. Epub 2019 Feb 5. Review.

PMID:
30735757
8.

Increased HLA-G Expression in Term Placenta of Women with a History of Recurrent Miscarriage Despite Their Genetic Predisposition to Decreased HLA-G Levels.

Craenmehr MHC, Nederlof I, Cao M, Drabbels JJM, Spruyt-Gerritse MJ, Anholts JDH, Kapsenberg HM, Stegehuis JA, van der Keur C, Fasse E, Haasnoot GW, van der Hoorn MP, Claas FHJ, Heidt S, Eikmans M.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E625. doi: 10.3390/ijms20030625.

9.

Presence of intragraft B cells during acute renal allograft rejection is accompanied by changes in peripheral blood B cell subsets.

Heidt S, Vergunst M, Anholts JDH, Swings GMJS, Gielis EMJ, Groeneweg KE, Witkamp MJ, de Fijter JW, Reinders MEJ, Roelen DL, Eikmans M, Claas FHJ.

Clin Exp Immunol. 2019 Jun;196(3):403-414. doi: 10.1111/cei.13269. Epub 2019 Feb 17.

10.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

11.

Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.

van der Zwan A, van der Meer-Prins EMW, van Miert PPMC, van den Heuvel H, Anholts JDH, Roelen DL, Claas FHJ, Heidt S.

Front Immunol. 2018 Dec 6;9:2880. doi: 10.3389/fimmu.2018.02880. eCollection 2018.

12.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
13.

An Easy and Sensitive Method to Profile the Antibody Specificities of HLA-specific Memory B Cells.

Karahan GE, Krop J, Wehmeier C, de Vaal YJH, Langerak-Langerak J, Roelen DL, Lardy NM, Bemelman FJ, Ten Berge IJM, Reinders MEJ, van Kooten C, Claas FHJ, Heidt S.

Transplantation. 2019 Apr;103(4):716-723. doi: 10.1097/TP.0000000000002516.

14.

The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review.

Herrera-Gómez F, Del Aguila W, Tejero-Pedregosa A, Adler M, Padilla-Berdugo R, Maurtua-Briseño-Meiggs Á, Pascual J, Pascual M, San Segundo D, Heidt S, Álvarez FJ, Ochoa-Sangrador C, Lambert C.

Int Immunopharmacol. 2018 Dec;65:483-492. doi: 10.1016/j.intimp.2018.10.028. Epub 2018 Nov 1.

PMID:
30390595
15.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
16.

No Evidence for Cross-reactivity of Virus-specific Antibodies With HLA Alloantigens.

Heidt S, Feltkamp MC, Karahan GE, de Brouwer CS, Langerak-Langerak J, Mulder A, Claas FHJ.

Transplantation. 2018 Nov;102(11):1844-1849. doi: 10.1097/TP.0000000000002369.

PMID:
30346375
17.

The long and winding road towards epitope matching in clinical transplantation.

Kramer CSM, Israeli M, Mulder A, Doxiadis IIN, Haasnoot GW, Heidt S, Claas FHJ.

Transpl Int. 2019 Jan;32(1):16-24. doi: 10.1111/tri.13362. Epub 2018 Nov 26. Review.

PMID:
30341790
18.

Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.

Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2019 Feb;104(2):403-416. doi: 10.3324/haematol.2018.201665. Epub 2018 Sep 27.

19.

RiCRN1, a Crinkler Effector From the Arbuscular Mycorrhizal Fungus Rhizophagus irregularis, Functions in Arbuscule Development.

Voß S, Betz R, Heidt S, Corradi N, Requena N.

Front Microbiol. 2018 Sep 4;9:2068. doi: 10.3389/fmicb.2018.02068. eCollection 2018.

20.

Minimal data reporting standards for serological testing for histocompatibility.

Valenzuela NM, Askar M, Heidt S, Jindra P, Madbouly A, Pinelli D, Jackson A, Hidalgo LG.

Hum Immunol. 2018 Dec;79(12):865-868. doi: 10.1016/j.humimm.2018.08.008. Epub 2018 Aug 17.

PMID:
30125598
21.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

22.

Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies.

Karahan GE, Claas FHJ, Heidt S.

Transpl Int. 2018 Nov;31(11):1189-1197. doi: 10.1111/tri.13327. Epub 2018 Aug 24. Review.

PMID:
30091231
23.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

PMID:
30049681
24.

No evidence for cross-reactivity of virus-specific antibodies with HLA allo-antigens.

Heidt S, Feltkamp MC, Karahan GE, de Brouwer CS, Langerak-Langerak J, Mulder A, Claas FH.

Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002369. [Epub ahead of print]

PMID:
30015700
25.

Transplantation in highly sensitized patients: challenges and recommendations.

Heidt S, Claas FHJ.

Expert Rev Clin Immunol. 2018 Aug;14(8):673-679. doi: 10.1080/1744666X.2018.1498335. Epub 2018 Jul 13. Review.

PMID:
30004800
26.

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Rijkers M, Saris A, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Bierings R, Leebeek FWG, Jansen AJG, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2018 Oct;103(10):1741-1752. doi: 10.3324/haematol.2018.189365. Epub 2018 Jun 1.

27.

How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.

Heidt S, Haasnoot GW, Claas FHJ.

Curr Opin Organ Transplant. 2018 Aug;23(4):493-499. doi: 10.1097/MOT.0000000000000545. Review.

PMID:
29846197
28.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

29.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

30.

Formation of a transient amorphous solid in low density aqueous charged sphere suspensions.

Niu R, Heidt S, Sreij R, Dekker RI, Hofmann M, Palberg T.

Sci Rep. 2017 Dec 6;7(1):17044. doi: 10.1038/s41598-017-17106-6.

31.

Novel aspects of epitope matching and practical application in kidney transplantation.

Lim WH, Wong G, Heidt S, Claas FHJ.

Kidney Int. 2018 Feb;93(2):314-324. doi: 10.1016/j.kint.2017.08.008. Epub 2017 Oct 20. Review.

PMID:
29061333
32.

Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.

Heidt S, Haasnoot GW, van Rood JJ, Witvliet MD, Claas FHJ.

Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.

PMID:
28947279
33.

Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

D'Orsogna L, van den Heuvel H, van Kooten C, Heidt S, Claas FHJ.

Immunogenetics. 2017 Aug;69(8-9):631-641. doi: 10.1007/s00251-017-0989-3. Epub 2017 Jul 17. Review.

34.

Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia.

Lather HD, Gornik HL, Olin JW, Gu X, Heidt ST, Kim ESH, Kadian-Dodov D, Sharma A, Gray B, Jaff MR, Chi YW, Mace P, Kline-Rogers E, Froehlich JB.

JAMA Neurol. 2017 Sep 1;74(9):1081-1087. doi: 10.1001/jamaneurol.2017.1333.

35.

Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.

Kramer CSM, Roelen DL, Heidt S, Claas FHJ.

HLA. 2017 Jul;90(1):5-16. doi: 10.1111/tan.13038. Epub 2017 Apr 5. Review.

PMID:
28378521
36.

A Memory B Cell Crossmatch Assay for Quantification of Donor-Specific Memory B Cells in the Peripheral Blood of HLA-Immunized Individuals.

Karahan GE, de Vaal YJH, Krop J, Wehmeier C, Roelen DL, Claas FHJ, Heidt S.

Am J Transplant. 2017 Oct;17(10):2617-2626. doi: 10.1111/ajt.14293. Epub 2017 May 3.

37.

Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients.

Bank JR, Heidt S, Moes DJ, Roelen DL, Mallat MJ, van der Boog PJ, Vergunst M, Jol-van der Zijde CM, Bredius RG, Braat AE, Ringers J, van Tol MJ, Claas FH, Reinders ME, de Fijter JW.

Transplant Direct. 2016 Dec 19;3(1):e124. doi: 10.1097/TXD.0000000000000634. eCollection 2017 Jan.

38.

Regulatory B cells: Phenotype, function and role in transplantation.

Wortel CM, Heidt S.

Transpl Immunol. 2017 Mar;41:1-9. doi: 10.1016/j.trim.2017.02.004. Epub 2017 Mar 1. Review.

39.

Epitope-Based HLA Matching: A Useful Strategy With Many Shortcomings to Overcome.

Claas FHJ, Heidt S.

Transplantation. 2017 Aug;101(8):1744-1745. doi: 10.1097/TP.0000000000001705. No abstract available.

PMID:
28252563
40.

B Cell Immunity in Solid Organ Transplantation.

Karahan GE, Claas FH, Heidt S.

Front Immunol. 2017 Jan 10;7:686. doi: 10.3389/fimmu.2016.00686. eCollection 2016. Review.

41.

Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions.

Heidt ST, Kratz A, Najarian K, Hassett AL, Oral H, Gonzalez R, Nallamothu BK, Clauw D, Ghanbari H.

J Atr Fibrillation. 2016 Jun 30;9(1):1422. doi: 10.4022/jafib.1422. eCollection 2016 Jun-Jul. Review.

42.

Symbiotic Fungi Control Plant Root Cortex Development through the Novel GRAS Transcription Factor MIG1.

Heck C, Kuhn H, Heidt S, Walter S, Rieger N, Requena N.

Curr Biol. 2016 Oct 24;26(20):2770-2778. doi: 10.1016/j.cub.2016.07.059. Epub 2016 Sep 15.

43.

Diagnosed and living with fibromuscular dysplasia: A qualitative inquiry.

Bumpus SM, Kuck C, Heidt ST, Bluhm M.

Vasc Med. 2016 Dec;21(6):539-546. Epub 2016 Oct 6.

PMID:
27758900
44.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
45.

Preventing Memory B Cell Formation: A Story of Mice and Men?

Heidt S, Claas FH.

Transplantation. 2016 Aug;100(8):1605-6. doi: 10.1097/TP.0000000000001254. No abstract available.

PMID:
27362318
46.

What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?

Craenmehr MH, Heidt S, Eikmans M, Claas FH.

HLA. 2016 Feb;87(2):69-78. doi: 10.1111/tan.12737. Epub 2016 Feb 3. Review.

PMID:
26841054
47.

"Rare" diseases: Motivated patients make the difference.

Kuck CE, Heidt ST, Kline-Rogers E.

Int J Cardiol. 2016 Apr 1;208:95-6. doi: 10.1016/j.ijcard.2016.01.199. Epub 2016 Jan 21. No abstract available.

PMID:
26836493
48.

Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection.

Rekers NV, Bajema IM, Mallat MJ, Petersen B, Anholts JD, Swings GM, van Miert PP, Kerkhoff C, Roth J, Popp D, van Groningen MC, Baeten D, Goemaere N, Kraaij MD, Zandbergen M, Heidt S, van Kooten C, de Fijter JW, Claas FH, Eikmans M.

Am J Transplant. 2016 May;16(5):1441-55. doi: 10.1111/ajt.13634. Epub 2016 Feb 1.

49.

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.

Reinders ME, Dreyer GJ, Bank JR, Roelofs H, Heidt S, Roelen DL, Zandvliet ML, Huurman VA, Fibbe WE, van Kooten C, Claas FH, Rabelink TJ, de Fijter JW.

J Transl Med. 2015 Nov 4;13:344. doi: 10.1186/s12967-015-0700-0.

50.

The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients.

Heidt S, Witvliet MD, Haasnoot GW, Claas FH.

Transpl Immunol. 2015 Oct;33(2):51-7. doi: 10.1016/j.trim.2015.08.006. Epub 2015 Aug 29.

PMID:
26325207

Supplemental Content

Support Center